Advanced Search

per page
  Report Title Date Provider Type Pgs Price

Synageva BioPharma Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

18 Apr 2014 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - SYNAGEVA BIOPHARMA CORP (GEVA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

23 Apr 2014 Thomson Reuters Stock Report 11 $25.00

GEVA: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

23 Apr 2014 New Constructs, LLC 5 $25.00

Synageva BioPharma Corp. (GEVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Synageva BioPharma Corp. (GEVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Synageva BioPharma Corp....

21 Apr 2014 GlobalData 31 $250.00

SYNAGEVA BIOPHARMA CP (GEVA) 12-months forecast

", the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

19 Apr 2014 Pechala's Reports 1 $15.00

ValuEngine Detailed Valuation Report for GEVA

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

17 Apr 2014 ValuEngine, Inc. 11 $25.00


17 Apr 2014 Ford Investor Services, Inc. 1 $12.00 Ratings Stock Report For: SYNAGEVA BIOPHARMA CORP (GEVA)

13 Apr 2014 Ratings 5 $10.00

GEVA - Synageva BioPharma Corp - Downgraded to a Sell - Company Analysis and ASR Ranking Report - Full Coverage of 3,000 U.S. equities. Reports include Financials, Ratios, Competitor Comparison...

12 Apr 2014 Alpha Street Research 9 $24.00

SYNAGEVA BIOPHM (GEVA) Zacks Company Snapshot

09 Apr 2014 Zacks Investment Research Inc. 1 $12.00